The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-AStéphane Dedieu(Centre National de la Recherche Scientifique), Sophie North(Université de Bordeaux)BMC MedicineMarch 24, 201010.1186/1741-7015-8-19Cited by 23SaveCiteExport RISWatch citationsRelated PapersLRP-1 Promotes Cancer Cell Invasion by Supporting ERK and Inhibiting JNK Signaling Pathways|PLoS ONE|2010|94Identification of TAX2 peptide as a new unpredicted anti-cancer agent|Oncotarget|2015|43